JEFFERSON CITY, Mo. (AP) — Missouri is resuming use of the Johnson & Johnson COVID-19 vaccine after federal scientific advisers decided its benefits outweigh a rare risk of blood clots.
The state made the announcement Friday night in a tweet in response to U.S. health officials lifting an 11-day pause on the single-dose vaccine.
The state said that providers with J&J vaccine in stock can immediately begin administering it and that shipments from the federal government will resume next week. Just over 105,000 doses of J&J had been administered in Missouri before the pause.